Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplasms, Plasma Cell × 30 days × Clear all

NCT07586709 2026-05-14

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

Phase EARLY_PHASE1 Not yet recruiting

Neoplasms, Plasma Cell